166 related articles for article (PubMed ID: 12396541)
1. Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy.
Sheng WH; Hung CC; Chen MY; Hsieh SM; Chang SC
Int J STD AIDS; 2002 Oct; 13(10):702-5. PubMed ID: 12396541
[TBL] [Abstract][Full Text] [Related]
2. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
Negroni R; Helou SH; López Daneri G; Robles AM; Arechavala AI; Bianchi MH
Rev Argent Microbiol; 2004; 36(3):113-7. PubMed ID: 15559192
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
Aberg JA; Price RW; Heeren DM; Bredt B
J Infect Dis; 2002 Apr; 185(8):1179-82. PubMed ID: 11930330
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
[TBL] [Abstract][Full Text] [Related]
5. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Skiest DJ; Hester LJ; Hardy RD
J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
[TBL] [Abstract][Full Text] [Related]
7. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy.
Sun HY; Chen MY; Hsiao CF; Hsieh SM; Hung CC; Chang SC
Clin Microbiol Infect; 2006 Apr; 12(4):381-8. PubMed ID: 16524416
[TBL] [Abstract][Full Text] [Related]
8. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
[TBL] [Abstract][Full Text] [Related]
9. Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Rambeloarisoa J; Batisse D; Thiebaut JB; Mikol J; Mrejen S; Karmochkine M; Kazatchkine MD; Weiss L; Piketty C
J Infect; 2002 Apr; 44(3):185-8. PubMed ID: 12099747
[TBL] [Abstract][Full Text] [Related]
10. Cessation of secondary prophylaxis in patients with cryptococcosis.
Nwokolo NC; Fisher M; Gazzard BG; Nelson MR
AIDS; 2001 Jul; 15(11):1438-9. PubMed ID: 11504967
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
Lilleri D; Piccinini G; Genini E; Comolli G; Chiesa A; Tordato F; Sotgiu G; Parisi A; Baldanti F; Revello MG; Gerna G
J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART.
Chaiwarith R; Charoenyos N; Sirisanthana T; Supparatpinyo K
AIDS; 2007 Jan; 21(3):365-7. PubMed ID: 17255744
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.
Cantey PT; Stephens DS; Rimland D
HIV Med; 2005 Jul; 6(4):253-9. PubMed ID: 16011530
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
Rollot F; Bossi P; Tubiana R; Caumes E; Zeller V; Katlama C; Bricaire F
AIDS; 2001 Jul; 15(11):1448-9. PubMed ID: 11504971
[No Abstract] [Full Text] [Related]
16. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
[TBL] [Abstract][Full Text] [Related]
17. Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/µL and Receiving Antiretroviral Therapy.
Sungkanuparph S; Savetamornkul C; Pattanapongpaiboon W
Clin Infect Dis; 2017 Apr; 64(7):967-970. PubMed ID: 28362939
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
[TBL] [Abstract][Full Text] [Related]
19. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy.
Boschi A; Tinelli C; Ortolani P; Moscatelli G; Morigi G; Arlotti M
AIDS; 2004 Dec; 18(18):2381-9. PubMed ID: 15622314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
